2025
P-332 Does endometrial thickness impact live birth rate following a frozen embryo transfer or is there a self-fulfilling prophecy: outcomes of 30,676 euploid single embryo transfers
Genovese H, Mayo C, Kalafat E, Ata B, Fatemi H, Garcia-Velasco J, Seli E. P-332 Does endometrial thickness impact live birth rate following a frozen embryo transfer or is there a self-fulfilling prophecy: outcomes of 30,676 euploid single embryo transfers. Human Reproduction 2025, 40: deaf097.640. DOI: 10.1093/humrep/deaf097.640.Peer-Reviewed Original ResearchLive birth rateModified natural cycleEndometrial thicknessReceiver operating characteristic curveBirth rateFET cyclesEmbryo transferInternational multicenter retrospective cohort studyOdds of live birth rateEuploid single embryo transfersPredictor of live birth rateMulticenter retrospective cohort studyEuploid FET cyclesEndometrial preparation protocolsIn vitro fertilization centerMultivariate logistic regression analysisSingle embryo transferFrozen embryo transferImpact of ETRetrospective cohort studyPredicting live birthLogistic regression analysisOperating characteristics curvePercentage of cyclesEuploid blastocysts
2024
The Prognostic and Predictive Value of RUNX1 Mutations in Newly Diagnosed Acute Myeloid Leukemia - an International Multicenter Cohort Study
Bystrom R, Bewersdorf J, Liu Y, Schaefer E, Shallis R, Boussi L, Zucenka A, Garciaz S, Aguirre L, DeAngelo D, Stone R, Luskin M, Garcia J, Winer E, Chen E, Wadleigh M, Ling K, Stein E, Goldberg A, Zeidan A, Shimony S, Stahl M. The Prognostic and Predictive Value of RUNX1 Mutations in Newly Diagnosed Acute Myeloid Leukemia - an International Multicenter Cohort Study. Blood 2024, 144: 2947-2947. DOI: 10.1182/blood-2024-205581.Peer-Reviewed Original ResearchAcute myeloid leukemiaComposite complete responseMedian OSRUNX1 mutationsComplete responseIntensive chemotherapyOverall survivalMyelodysplastic syndromeAllo-SCTIntermediate riskPredictive valueMyeloid leukemiaInternational multicenter retrospective cohort studyTreatment strategiesCohort studyNewly diagnosed acute myeloid leukemiaAllogeneic stem cell transplantationMulticenter retrospective cohort studyNext-generation sequencingAntecedent MDSConcomitant TP53 mutationIncomplete count recoveryTreated with ICStem cell transplantationAdverse risk features
2022
Cytomegalovirus-related Complications and Management in Facial Vascularized Composite Allotransplantation: An International Multicenter Retrospective Cohort Study
Kauke-Navarro M, Panayi AC, Formica R, Marty F, Parikh N, Foroutanjazi S, Safi AF, Mardini S, Razonable RR, Morelon E, Gelb B, Rodriguez E, Lassus P, Pomahac B. Cytomegalovirus-related Complications and Management in Facial Vascularized Composite Allotransplantation: An International Multicenter Retrospective Cohort Study. Transplantation 2022, 106: 2031-2043. PMID: 35389381, DOI: 10.1097/tp.0000000000004132.Peer-Reviewed Original ResearchConceptsRetrospective cohort studyAntiviral prophylaxisCohort studyComposite allotransplantationInternational multicenter retrospective cohort studyMulticenter retrospective cohort studyCMV-related complicationsFirst year posttransplantHigh-risk transplantsMore rejection episodesHigh-risk groupFacial Vascularized Composite AllotransplantationAllograft-related complicationsVascularized Composite AllotransplantationPaucity of dataAllograft lossCMV diseaseCMV viremiaCytomegalovirus serostatusR serostatusRejection episodesCMV infectionPrompt treatmentActive surveillancePatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply